Answers are grounded in this paper and cite their sources.
Erythronolide B, a presumed intermediate in the biosynthesis of the erythromycins, has been shown to be formed from 6-deoxyerythronolide B by hydroxylation at C-6. The substrate, a metabolite of a blocked mutant of Streptomyces erythreus and postulated to be an intermediate in the biosynthesis of the erythromycins, is found also in wild-type cultures of S. erythreus CA340 either normally or in increased amount when an inhibitor of NADPH function is present. The hydroxylation of 6-deoxyerythronolide B is catalyzed by a stable and soluble cell-free enzyme preparation obtained from noninduced S. erythreus CA340, and the maximal specific activity of the hydroxylase system is found with the protein fraction precipitating between 50% and 90% of saturation with ammonium sulfate. The hydroxylase activity correlates well with the specific content of a cytochrome P-450 moiety present in the system and is inhibited by anaerobiosis and carbon monoxide.
No takes yet. Share an insight, caveat, or question.
Corcoran et al. (1982) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: